Leena Gandhi - Apr 4, 2023 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role: Director
Signature: /s/John Rudy, attorney-in-fact
Stock symbol: NEXI
Transactions as of: Apr 4, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/6/2023, 08:43 PM
Previous filing: May 9, 2022
Next filing: Jul 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEXI	Stock Option (right to buy)	Disposed to Issuer	-80.9K	-100%	0	Apr 4, 2023	Common Stock	80.9K	$3.07	Direct	F1
transaction	NEXI	Stock Option (right to buy)	Award	+36K		36K	Apr 4, 2023	Common Stock	36K	$1.64	Direct	F1
transaction	NEXI	Stock Option (right to buy)	Award	+45K		45K	Apr 4, 2023	Common Stock	45K	$1.23	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 5, 2022, of which 24,733 shares vested, and the remainder of the options will vest in equal monthly installments such that on May 5, 2025, all shares subject to the option shall be vested, subject to Ms. Gandhi's continued service on each vesting date.

Content

The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 5, 2022, of which 24,733 shares vested, and the remainder of the options will vest in equal monthly installments such that on May 5, 2025, all shares subject to the option shall be vested, subject to Ms. Gandhi's continued service on each vesting date.